Wanga, Valentine
,
Baeten, Jared M.
Bukusi, Elizabeth A.
Mugo, Nelly R.
Asiimwe, Stephen
Ngure, Kenneth
Mujugira, Andrew
Muwonge, Timothy
Odoyo, Josephine B.
Haberer, Jessica E.
Celum, Connie
Heffron, Renee http://orcid.org/0000-0001-6039-0352
Funding for this research was provided by:
National Institute of Mental Health (R01MH095507)
Bill and Melinda Gates Foundation (OPP1056051)
USAID (AID-OAA-A-12-00023)
Article History
First Online: 10 January 2020
Compliance with Ethical Standards
:
: Gilead Sciences donated the PrEP medication but had no role in data collection or analysis. The authors disclosed no competing interests.
: The study protocol was approved by the Human Subjects Division at the University of Washington (#STUDY00001674) and Ethics Review Committees overseeing each study site: Scientific Ethics Review Unit at the Kenya Medical Research Institute (SSC No. 2441), the Ethics Review Committee of Kenyatta National Hospital (P286/05/2012), and the AIDS Research Committee of the Uganda National Council of Science and Technology (ARC 135 and ARC126).
: All participants provided written informed consent.